Sleep Number Corporation (Nasdaq: SNBR) today reported results for the quarter ended July 1, 2023.
“As we continue to navigate a challenging macro environment, our business is well positioned for growth. Demand has steadily improved year-to-date, and we expect this trend to continue in the back-half of the year as we benefit from the launch of our entire next generation smart bed portfolio, the Climate360 smart bed, and the advancement of our ‘Sleep Next Level’ advertising campaign with the start of the NFL season,” said Shelly Ibach, Chair, President and CEO, Sleep Number. “We have taken actions across the business to drive efficiencies and remain on track to expand margins and generate more than $100 million in cash from operations in 2023.”
Today, Sleep Number also announced the appointment of Francis Lee to Executive Vice President and Chief Financial Officer. Details can be found on the Sleep Number newsroom.
Second Quarter Overview
- Net sales decreased 16% to $459 million, with demand down mid-single digits; demand improved throughout the second quarter, although slightly below our expectations
- Gross margin was 57.6% and in line with our expectations; as a reminder prior year second quarter results benefitted from the delivery of more than $100 million in margin-rich backlog
- Operating expenses were reduced by $22 million to $253 million compared with $275 million last year
- Earnings per diluted share of $0.03 compared with $1.54 for the same period last year
Year-to-Date Overview
- Net sales decreased 8% to $985 million, with demand down high-single digits versus prior year
- Gross profit decreased to $575 million compared with $627 million for the prior year; gross margin rate of 58.3% was consistent with the same period last year and up 290 bp versus the back half of last year
- Operating income of $37 million compared with $54 million last year, with an 8% decline in gross margin dollars, partially offset by a $36 million reduction in operating expenses
- Earnings per diluted share of $0.54 compared with $1.60 for the same period last year
Cash Flows Overview
- Net cash from operating activities of $19 million for the first six months of the year, compared with $29 million for the same period last year
- Leverage ratio of 4.7x EBITDAR at the end of the second quarter versus covenant maximum of 5.0x
- Adjusted ROIC of 12.3% for the trailing twelve months
Financial Outlook
The company updated its full-year 2023 diluted EPS outlook to a range of $1.25 to $1.75. The 2023 outlook assumes net sales are down low to mid-single digits versus the prior year and gross margin improvement of more than 150 basis points versus 2022. The company expects to generate more than $100 million of operating cash flow for the year and positive free cash flows. The company anticipates 2023 capital expenditures of $50 million to $60 million.
Conference Call Information
Management will host its regularly scheduled conference call to discuss the company’s results at 5 p.m. EDT (4 p.m. CDT; 2 p.m. PDT) today. To access the webcast, please visit the investor relations area of the Sleep Number website at https://ir.sleepnumber.com. The webcast replay will remain available for approximately 60 days.
About Sleep Number Corporation
Sleep Number is a wellness technology company. We are guided by our purpose to improve the health and wellbeing of society through higher quality sleep; to date, our innovations have improved over 14.5 million lives. Our wellness technology platform helps solve sleep problems, whether it’s providing individualized temperature control for each sleeper through our Climate360® smart bed or applying our 21 billion hours of longitudinal sleep data and expertise to research with global institutions.
Our smart bed ecosystem drives best-in-class engagement through dynamic, adjustable, and effortless sleep with personalized digital sleep and health insights; our millions of smart sleepers are loyal brand advocates. And our nearly 5,000 mission-driven team members passionately innovate to drive value creation through our vertically integrated business model, including our exclusive direct-to-consumer selling in 670 stores and online.
To learn more about life-changing, individualized sleep, visit a Sleep Number store near you, our newsroom. and investor relations sites, or SleepNumber.com
Forward-looking Statements
Statements used in this news release relating to future plans, events, financial results or performance, such as the company’s financial outlook for full-year 2023, including diluted EPS, are forward-looking statements subject to certain risks and uncertainties including, among others, such factors as current and future economic conditions and consumer sentiment; bank failures or other events affecting financial institutions; increases in interest rates, which have increased the cost of servicing the company’s indebtedness; availability of attractive and cost-effective consumer credit options; operating with minimal levels of inventory, which may leave the company vulnerable to supply shortages; Sleep Number’s dependence on, and ability to maintain strong working relationships with key suppliers and third parties; rising commodity costs or third-party logistics costs and other inflationary pressures; risks inherent in global-sourcing activities, including tariffs, geo-political turmoil, war, strikes, labor challenges, government-mandated work closures, outbreaks of pandemics or contagious diseases, and resulting supply shortages and production and delivery delays and disruptions; risks of disruption due to health epidemics or pandemics, such as the COVID-19 pandemic; regional risks related to having global operations and suppliers, including climate and other disasters; the effectiveness of the company’s marketing strategy and promotional efforts; the execution of Sleep Number’s Total Retail distribution strategy; ability to achieve and maintain high levels of product quality; ability to improve and expand Sleep Number’s product line and execute successful new product introductions; ability to prevent third parties from using the company’s technology or trademarks, and the adequacy of its intellectual property rights to protect its products and brand; ability to compete; risks of disruption in the operation of any of the company’s main manufacturing, distribution, logistics, home delivery, product development or customer service operations; the company’s ability to comply with existing and changing government regulation; pending or unforeseen litigation and the potential for associated adverse publicity; the adequacy of the company’s and third-party information systems and costs and disruptions related to upgrading or maintaining these systems; the company’s ability to withstand cyber threats that could compromise the security of its systems, result in a data breach or business disruption; Sleep Number’s ability, and the ability of its suppliers and vendors, to attract, retain and motivate qualified personnel; the volatility of Sleep Number stock; environmental, social and governance (ESG) risks, including increasing regulation and stakeholder expectations; and the company’s ability to adapt to climate change and readiness for legal or regulatory responses thereto. Additional information concerning these and other risks and uncertainties is contained in the company’s filings with the Securities and Exchange Commission (SEC), including the Annual Report on Form 10-K, and other periodic reports filed with the SEC. The company has no obligation to publicly update or revise any of the forward-looking statements in this news release.
| SLEEP NUMBER CORPORATION AND SUBSIDIARIES Consolidated Statements of Operations (unaudited – in thousands, except per share amounts) | |||||||||
Three Months Ended | |||||||||
July 1,
| % of Net Sales | July 2,
| % of Net Sales | ||||||
Net sales | $ | 458,789 | 100.0% | $ | 549,073 | 100.0% | |||
Cost of sales | 194,544 | 42.4% | 224,128 | 40.8% | |||||
Gross profit | 264,245 | 57.6% | 324,945 | 59.2% | |||||
Operating expenses: | |||||||||
Sales and marketing | 197,779 | 43.1% | 220,490 | 40.2% | |||||
General and administrative | 39,795 | 8.7% | 38,727 | 7.1% | |||||
Research and development | 15,445 | 3.4% | 15,817 | 2.9% | |||||
Total operating expenses | 253,019 | 55.1% | 275,034 | 50.1% | |||||
Operating income | 11,226 | 2.4% | 49,911 | 9.1% | |||||
Interest expense, net | 9,948 | 2.2% | 3,619 | 0.7% | |||||
Income before income taxes | 1,278 | 0.3% | 46,292 | 8.4% | |||||
Income tax expense | 524 | 0.1% | 11,359 | 2.1% | |||||
Net income | $ | 754 | 0.2% | $ | 34,933 | 6.4% | |||
Net income per share – basic | $ | 0.03 | $ | 1.56 | |||||
Net income per share – diluted | $ | 0.03 | $ | 1.54 | |||||
Reconciliation of weighted-average shares outstanding: | |||||||||
Basic weighted-average shares outstanding | 22,460 | 22,355 | |||||||
Dilutive effect of stock-based awards | 42 | 358 | |||||||
Diluted weighted-average shares outstanding | 22,502 | 22,713 | |||||||
SLEEP NUMBER CORPORATION AND SUBSIDIARIES Consolidated Statements of Operations (unaudited – in thousands, except per share amounts) | |||||||||
Six Months Ended | |||||||||
July 1,
| % of Net Sales | July 2,
| % of Net Sales | ||||||
Net sales | $ | 985,316 | 100.0% | $ | 1,076,203 | 100.0% | |||
Cost of sales | 410,806 | 41.7% | 448,960 | 41.7% | |||||
Gross profit | 574,510 | 58.3% | 627,243 | 58.3% | |||||
Operating expenses: | |||||||||
Sales and marketing | 428,267 | 43.5% | 460,749 | 42.8% | |||||
General and administrative | 79,196 | 8.0% | 80,046 | 7.4% | |||||
Research and development | 29,888 | 3.0% | 32,122 | 3.0% | |||||
Total operating expenses | 537,351 | 54.5% | 572,917 | 53.2% | |||||
Operating income | 37,159 | 3.8% | 54,326 | 5.0% | |||||
Interest expense, net | 19,050 | 1.9% | 5,746 | 0.5% | |||||
Income before income taxes | 18,109 | 1.8% | 48,580 | 4.5% | |||||
Income tax expense | 5,890 | 0.6% | 11,573 | 1.1% | |||||
Net income | $ | 12,219 | 1.2% | $ | 37,007 | 3.4% | |||
Net income per share – basic | $ | 0.55 | $ | 1.64 | |||||
Net income per share – diluted | $ | 0.54 | $ | 1.60 | |||||
Reconciliation of weighted-average shares outstanding: | |||||||||
Basic weighted-average shares outstanding | 22,378 | 22,558 | |||||||
Dilutive effect of stock-based awards | 165 | 594 | |||||||
Diluted weighted-average shares outstanding | 22,543 | 23,152 | |||||||
SLEEP NUMBER CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (unaudited – in thousands, except per share amounts) subject to reclassification | |||||||
July 1,
| December 31,
| ||||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 1,798 | $ | 1,792 | |||
Accounts receivable, net of allowances of $1,475 and $1,267, respectively | 24,102 | 26,005 | |||||
Inventories | 121,446 | 114,034 | |||||
Prepaid expenses | 21,029 | 16,006 | |||||
Other current assets | 40,142 | 39,921 | |||||
Total current assets | 208,517 | 197,758 | |||||
Non-current assets: | |||||||
Property and equipment, net | 191,067 | 200,605 | |||||
Operating lease right-of-use assets | 399,989 | 397,755 | |||||
Goodwill and intangible assets, net | 67,086 | 68,065 | |||||
Deferred income taxes | 16,230 | 7,958 | |||||
Other non-current assets | 82,266 | 81,795 | |||||
Total assets | $ | 965,155 | $ | 953,936 | |||
Liabilities and Shareholders’ Deficit | |||||||
Current liabilities: | |||||||
Borrowings under revolving credit facility | $ | 483,800 | $ | 459,600 | |||
Accounts payable | 152,205 | 176,207 | |||||
Customer prepayments | 58,498 | ||||||
